Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells.
about
Melatonin as a potential anticarcinogen for non-small-cell lung cancerOncostatic-Cytoprotective Effect of Melatonin and Other Bioactive Molecules: A Common Target in Mitochondrial RespirationHIF-1α Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27aBaclofen Protects Primary Rat Retinal Ganglion Cells from Chemical Hypoxia-Induced Apoptosis Through the Akt and PERK PathwaysMelatonin: shedding light on infertility?--A review of the recent literatureThe translation initiation factor eIF3i up-regulates vascular endothelial growth factor A, accelerates cell proliferation, and promotes angiogenesis in embryonic development and tumorigenesis.Effects of Melatonin on Liver Injuries and Diseases.Melatonin Reduces Angiogenesis in Serous Papillary Ovarian Carcinoma of Ethanol-Preferring RatsMelatonin enhances the anti-tumor effect of fisetin by inhibiting COX-2/iNOS and NF-κB/p300 signaling pathways.Melatonin for the prevention and treatment of cancerUpregulation of miRNA3195 and miRNA374b Mediates the Anti-Angiogenic Properties of Melatonin in Hypoxic PC-3 Prostate Cancer Cells.RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch.Emerging translational approaches to target STAT3 signalling and its impact on vascular diseaseMelatonin Activates Endoplasmic Reticulum Stress and Apoptosis in Rats with Diethylnitrosamine-Induced HepatocarcinogenesisCeramide metabolism regulates autophagy and apoptotic cell death induced by melatonin in liver cancer cells.Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell LinesTargeting inhibition of extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) suppresses growth and angiogenesis of gastric cancer.Melatonin downregulates nuclear receptor RZR/RORγ expression causing growth-inhibitory and anti-angiogenesis activity in human gastric cancer cells in vitro and in vivoVascular Endothelial Growth Factor and Cluster of Differentiation 34 for Assessment of Perioperative Bleeding Risk in Gastric Cancer Patients.Aspirin may inhibit angiogenesis and induce autophagy by inhibiting mTOR signaling pathway in murine hepatocarcinoma and sarcoma models.Impact of VEGF gene polymorphisms in elderly cancer patients: clinical outcome and toxicity.Melatonin as a treatment for gastrointestinal cancer: a review.Activation of protease-activated receptor 2 reduces glioblastoma cell apoptosis.Inhibition of the SphK1/S1P signaling pathway by melatonin in mice with liver fibrosis and human hepatic stellate cells.Anti-angiogenic activity of thienopyridine derivative LCB03-0110 by targeting VEGFR-2 and JAK/STAT3 Signalling.LB-1 Exerts Antitumor Activity in Pancreatic Cancer by Inhibiting HIF-1α and Stat3 Signaling.VEGF-mediated suppression of cell proliferation and invasion by miR-410 in osteosarcoma.MiR-718 represses VEGF and inhibits ovarian cancer cell progression.STAT3 activation in infection and infection-associated cancer.Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1-phosphate signaling pathway in a mouse model of diethylnitrosamine-induced hepatocellular carcinoma.The impact of high co-expression of Sp1 and HIF1α on prognosis of patients with hepatocellular cancer.Melatonin inhibits TPA-induced oral cancer cell migration by suppressing matrix metalloproteinase-9 activation through the histone acetylation.Down-regulation of microRNA-9 leads to activation of IL-6/Jak/STAT3 pathway through directly targeting IL-6 in HeLa cell.Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy.Melatonin and Hippo Pathway: Is There Existing Cross-Talk?Effects of melatonin on HIF-1α and VEGF expression and on the invasive properties of hepatocarcinoma cells.The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis.Melanoma topology reveals a stem-like phenotype that promotes angiogenesis.Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells.Melatonin suppresses hepatocellular carcinoma progression via lncRNA-CPS1-IT-mediated HIF-1α inactivation.
P2860
Q26751220-94567989-215D-4FA8-9E52-5F5F859AD5A0Q26766876-C2A465FF-16F9-46E8-BAAA-2C6F977B0696Q28547382-4ABF4FE9-72FE-4C77-8CA8-E58E31DE519DQ28822200-E50C693E-555C-4973-B551-8094BAC3EB84Q28917092-115008A4-58A9-4883-939B-8FADCD496ABEQ30591171-CAAD60F0-B9B9-45AE-9A0A-32CEEC4BC23CQ33624211-8C2A700F-69B0-4119-A342-72CBD7299E44Q33624518-10CC3322-7F93-478F-A638-6D4904E1B14DQ33856716-578E2EF8-F129-4218-B5BE-EC860D2FC8C5Q33889427-9A7C35EA-CC0C-4F72-8405-1A7031F309F3Q34784899-6355A513-5D27-4E43-ACD5-AC32CB129BB7Q35130808-7FB37A75-D160-45DA-AE60-E23CF70DF1B4Q35580177-02BA79CA-ED9F-4E7B-AF33-2EFEDC94F214Q35866050-19894547-A47C-4883-984D-181575E71D6BQ35912091-CE546FF3-450B-4244-837F-E669ED458316Q35943145-FE74D912-7058-40D1-9D76-A6594251523BQ36280358-F2514601-F261-42B3-B6AD-55AA81ABE4DEQ37108056-54F0BFF9-40B5-4FFD-89E7-0BE18D60B4A0Q37185449-1275DF25-54DC-46DD-BF2A-F694EC132A2BQ37287539-09C12483-CED5-400E-A58D-6F624CCB1615Q38307997-AC29D923-8E38-4BA7-BE71-84BB362FA9F3Q38370739-FF3AF542-271A-4CC8-A744-BF00B289DAD9Q38601524-BF45923D-F012-4F81-B813-E7F00E255683Q38734564-5234356A-BFE8-43F5-A1DE-1336B30E4523Q38895275-0E665E4F-187C-4A40-9D61-BA3A18C52E5CQ38912642-0076A436-C964-4BA3-9B42-2F008734CBDBQ38941347-122D54F3-F7C3-4726-9CEF-F0083A152433Q38996307-301B07E3-0CA4-4BC6-BB38-3AA9C37DC5BCQ39145689-169F8D1E-42B5-4082-8432-2F183C7271C2Q39328422-DBA36EF3-0D8D-4EC7-AA08-C1C98F015E66Q40680671-16D960DB-5049-4AFB-BC19-D29F859BF7FBQ40996633-EA78F713-F51B-4229-96CF-19768EE5EC41Q41384312-D4B694F6-A438-47B4-8536-2D33393525F7Q41651606-FBF2011A-119B-4F3E-987D-5C78259DA374Q41660894-B28C48EF-7762-49EB-849D-AE887B7D3785Q41880464-45990C36-7E8B-4D26-A05F-9CFFDFA9982CQ42366665-D61EDD18-C77F-43CD-B092-BC0599B9AD05Q42631326-069E76B1-11D0-4D32-B6DC-5DD8A4CA98FEQ43778009-16A9EE39-7520-41C5-9141-1AED93B055B4Q45394478-940741EC-9D48-4B14-AA80-2C2D5BFF45D8
P2860
Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Inhibition of VEGF expression ...... n in HepG2 liver cancer cells.
@en
Inhibition of VEGF expression ...... n in HepG2 liver cancer cells.
@nl
type
label
Inhibition of VEGF expression ...... n in HepG2 liver cancer cells.
@en
Inhibition of VEGF expression ...... n in HepG2 liver cancer cells.
@nl
prefLabel
Inhibition of VEGF expression ...... n in HepG2 liver cancer cells.
@en
Inhibition of VEGF expression ...... n in HepG2 liver cancer cells.
@nl
P2093
P2860
P50
P356
P1476
Inhibition of VEGF expression ...... in in HepG2 liver cancer cells
@en
P2093
A García-Palomo
P2860
P2888
P356
10.1038/BJC.2013.285
P407
P577
2013-06-11T00:00:00Z